株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

酒さ治療薬の世界市場:成長動向・競合分析

Global Rosacea Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

発行 QYResearch 商品コード 798061
出版日 ページ情報 英文 119 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.74円で換算しております。
Back to Top
酒さ治療薬の世界市場:成長動向・競合分析 Global Rosacea Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
出版日: 2019年03月04日 ページ情報: 英文 119 Pages
概要

当レポートでは、世界の酒さ治療薬の市場を調査し、市場および製品の概要、販売数・収益・価格などの推移と予測、タイプ・用途・地域別の内訳、製造・販売などの動向、市場成長への各種影響因子の分析、競合環境と市場シェア、主要製造業者のプロファイルなどをまとめています。

第1章 レポート概要

  • 調査範囲
  • 調査対象製造業者
  • 市場区分:タイプ別
    • 成長率:タイプ別
    • 局所治療薬
    • 経口薬
  • 市場区分:用途別
    • 市場シェア:用途別
    • ドラッグストア
    • 病院
    • その他
  • 調査対象
  • 調査対象年

第2章 世界の成長動向

  • 販売数・収益の推移・予測
  • 成長率:地域別
  • 産業動向

第3章 製造業者の市場シェア

  • 販売数・販売数のシェア:製造業者別
  • 収益・収益のシェア:製造業者別
  • 価格:製造業者別
  • 主要製造業者の工場の分布・販売エリア
  • 主要製造業者の市場参入時期
  • 主要製造業者の提供製品
  • M&A・拡張計画

第4章 市場規模の推移:タイプ別

  • 販売数・収益の推移
  • 販売数のシェア
  • 収益のシェア
  • 価格

第5章 市場規模の推移:用途別

  • 概要
  • 販売数

第6章 北米市場の分析

  • 販売数の推移:企業別
  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • 米国
    • カナダ
    • メキシコ

第7章 欧州市場の分析

  • 販売数の推移:企業別
  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋市場の分析

  • 販売数の推移:企業別
  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • インドネシア
    • マレーシア
    • フィリピン
    • タイ
    • ベトナム

第9章 中南米市場の分析

  • 販売数の推移:企業別
  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • ブラジル

第10章 中東・アフリカ市場の分析

  • 販売数の推移:タイプ別
  • 販売数の推移:用途別
  • 販売数・収益の推移:国別
    • GCC諸国
    • エジプト
    • 南アフリカ

第11章 企業プロファイル

  • Nestle Skin Health
  • Teva
  • Mylan
  • Bayer
  • Sun Pharma
  • Perrigo
  • Bausch Health
  • GSK
  • Pfizer
  • Allergan
  • Almirall

第12章 バリューチェーン・販売経路の分析

第13章 市場予測

  • 販売数・収益の予測
  • 販売数の予測:タイプ別
  • 販売数の予測:用途別
  • 販売数・収益の予測:地域・国別

第14章 調査結果・総論

第15章 付録

図表

List of Tables and Figures

  • Figure Rosacea Drugs Product Picture
  • Table Rosacea Drugs Key Market Segments
  • Table Major Manufacturers Rosacea Drugs Covered in This Report
  • Table Global Rosacea Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
  • Figure Global Rosacea Drugs Sales Market Shar by Type 2014-2025
  • Figure Topical Figures
  • Table Major Manufacturers of Topical
  • Figure Orals Figures
  • Table Major Manufacturers of Orals
  • Table Global Rosacea Drugs Market Share by Application 2019-2025 (K Units)
  • Figure Drugs Stores Use Case
  • Figure Hospital Use Case
  • Figure Other Use Case
  • Figure Rosacea Drugs Report Years Considered
  • Figure Global Rosacea Drugs Market Size 2014-2025 (Million US$)
  • Figure Global Rosacea Drugs Sales 2014-2019 (K Units)
  • Table Global Rosacea Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
  • Table Global Rosacea Drugs Sales by Regions 2014-2019 (K Units)
  • Table Global Rosacea Drugs Sales Market Share by Regions 2014-2019
  • Figure Global Rosacea Drugs Sales Market Share by Regions 2014-2019
  • Figure Global Rosacea Drugs Sales Market Share by Regions in 2018
  • Table Global Rosacea Drugs Revenue by Regions 2014-2019 (Million US$)
  • Table Global Rosacea Drugs Revenue Market Share by Regions 2014-2019
  • Figure Global Rosacea Drugs Revenue Market Share by Regions 2014-2019
  • Figure Global Rosacea Drugs Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Rosacea Drugs Sales by Manufacturers (2014-2019) (K Units)
  • Table Global Rosacea Drugs Sales Share by Manufacturers (2014-2019)
  • Figure Global Rosacea Drugs Sales Share by Manufacturers in 2018
  • Table Rosacea Drugs Revenue by Manufacturers (2014-2019) (Million USD)
  • Table Rosacea Drugs Revenue Share by Manufacturers (2014-2019)
  • Figure Rosacea Drugs Value Share by Manufacturers in 2019
  • Table Global Rosacea Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Rosacea Drugs Price (2014-2019) (USD/Unit)
  • Table Key Manufacturers Rosacea Drugs Plants/Factories Distribution
  • Table Key Manufacturers Rosacea Drugs Area Served
  • Table Date of Key Manufacturers Enter into Rosacea Drugs Market
  • Table Key Manufacturers Rosacea Drugs Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Topical Sales and Revenue (2014-2019) (K Units) & (Million US$)
  • Table Global Orals Sales and Revenue (2014-2019) (K Units) & (Million US$)
  • Table Global Rosacea Drugs Sales by Type (2014-2019) (K Units)
  • Table Global Rosacea Drugs Sales Share by Type (2014-2019)
  • Figure Global Rosacea Drugs Sales Market Share by Type (2014-2019)
  • Figure Global Rosacea Drugs Sales Market Share by Type in 2018
  • Table Global Rosacea Drugs Revenue by Type (2014-2019) (Million US$)
  • Table Global Rosacea Drugs Revenue Share by Type (2014-2019)
  • Figure Global Rosacea Drugs Revenue Market Share by Type (2014-2019)
  • Figure Global Rosacea Drugs Revenue Market Share by Type in 2018
  • Table Rosacea Drugs Price by Type 2014-2019 (USD/Unit)
  • Table Global Rosacea Drugs Sales by Application (2014-2019) (K Units)
  • Table Global Rosacea Drugs Sales Share by Application (2014-2019)
  • Figure Global Sales Rosacea Drugs Market Share by Application (2014-2019)
  • Figure Global Sales Rosacea Drugs Market Share by Application in 2018
  • Figure North America Rosacea Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure North America Rosacea Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table North America Rosacea Drugs Sales by Company (2014-2019) (K Units)
  • Table North America Rosacea Drugs Sales Market Share by Company (2014-2019)
  • Figure North America Rosacea Drugs Sales Market Share by Company in 2019
  • Table North America Rosacea Drugs Sales by Type (2014-2019) (K Units)
  • Table North America Rosacea Drugs Sales Market Share by Type (2014-2019)
  • Figure North America Rosacea Drugs Market Share by Type in 2019
  • Table North America Rosacea Drugs Sales by Application (2014-2019) (K Units)
  • Table North America Rosacea Drugs Sales Market Share by Application (2014-2019)
  • Figure North America Rosacea Drugs Market Share by Application in 2019
  • Table North America Rosacea Drugs Sales by Countries (2014-2019) (K Units)
  • Table North America Rosacea Drugs Sales Market Share by Countries (2014-2019)
  • Figure 2017 North America Rosacea Drugs Sales Market Share by Countries
  • Table North America Rosacea Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table North America Rosacea Drugs Revenue Market Share by Countries (2014-2019)
  • Figure 2017 North America Rosacea Drugs Revenue Market Share by Countries
  • Figure United States Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Canada Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Mexico Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Europe Rosacea Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure Europe Rosacea Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table Europe Rosacea Drugs Sales by Company (2014-2019) (K Units)
  • Table Europe Rosacea Drugs Sales Market Share by Company (2014-2019)
  • Figure Europe Rosacea Drugs Sales Market Share by Company in 2019
  • Table Europe Rosacea Drugs Sales by Type (2014-2019) (K Units)
  • Table Europe Rosacea Drugs Sales Market Share by Type (2014-2019)
  • Figure 2017 Europe Rosacea Drugs Market Share by Type
  • Table Europe Rosacea Drugs Sales by Application (2014-2019) (K Units)
  • Table Europe Rosacea Drugs Sales Market Share by Application (2014-2019)
  • Figure 2017 Europe Rosacea Drugs Market Share by Application
  • Table Europe Rosacea Drugs Sales by Countries (2014-2019) (K Units)
  • Table Europe Rosacea Drugs Sales Market Share by Countries (2014-2019)
  • Figure 2017 Europe Rosacea Drugs Sales Market Share by Countries
  • Table Europe Rosacea Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table Europe Rosacea Drugs Revenue Market Share by Countries (2014-2019)
  • Figure Europe Rosacea Drugs Revenue Market Share by Countries in 2019
  • Figure Germany Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure France Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure UK Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Italy Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Russia Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Asia Pacific Rosacea Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure Asia Pacific Rosacea Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table Asia Pacific Rosacea Drugs Sales by Company (2014-2019) (K Units)
  • Table Asia Pacific Rosacea Drugs Sales Market Share by Company (2014-2019)
  • Figure Asia Pacific Rosacea Drugs Sales Market Share by Company in 2019
  • Table Asia Pacific Rosacea Drugs Sales by Type (2014-2019) (K Units)
  • Table Asia Pacific Rosacea Drugs Sales Market Share by Type (2014-2019)
  • Figure Asia Pacific Rosacea Drugs Market Share by Type in 2019
  • Table Asia Pacific Rosacea Drugs Sales by Application (2014-2019) (K Units)
  • Table Asia Pacific Rosacea Drugs Sales Market Share by Application (2014-2019)
  • Figure Asia Pacific Rosacea Drugs Market Share by Application in 2019
  • Table Asia Pacific Rosacea Drugs Sales by Countries (2014-2019) (K Units)
  • Table Asia Pacific Rosacea Drugs Sales Market Share by Countries (2014-2019)
  • Figure 2017 Asia Pacific Rosacea Drugs Sales Market Share by Countries
  • Table Asia Pacific Rosacea Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table Asia Pacific Rosacea Drugs Revenue Market Share by Countries (2014-2019)
  • Figure 2017 Asia Pacific Rosacea Drugs Revenue Market Share by Countries
  • Figure China Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure China Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Japan Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Japan Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Korea Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Korea Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure India Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure India Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Australia Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Australia Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Indonesia Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Indonesia Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Malaysia Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Malaysia Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Philippines Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Philippines Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Thailand Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Thailand Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Vietnam Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Vietnam Rosacea Drugs Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Central & South America Rosacea Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure Central & South America Rosacea Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table Central & South America Rosacea Drugs Sales by Company (2014-2019) (K Units)
  • Table Central & South America Rosacea Drugs Sales Market Share by Company (2014-2019)
  • Figure Central & South America Rosacea Drugs Sales Market Share by Company in 2018
  • Table Central & South America Rosacea Drugs Sales by Type (2014-2019) (K Units)
  • Table Central & South America Rosacea Drugs Sales Market Share by Type (2014-2019)
  • Figure Central & South America Rosacea Drugs Market Share by Type in 2019
  • Table Central & South America Rosacea Drugs Sales by Application (2014-2019) (K Units)
  • Table Central & South America Rosacea Drugs Sales Market Share by Application (2014-2019)
  • Figure Central & South America Rosacea Drugs Market Share by Application in 2019
  • Table Central & South America Rosacea Drugs Sales by Countries (2014-2019) (K Units)
  • Table Central & South America Rosacea Drugs Sales Market Share by Countries (2014-2019)
  • Figure Central & South America Rosacea Drugs Sales Market Share by Countries in 2019
  • Table Central & South America Rosacea Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table Central & South America Rosacea Drugs Revenue Market Share by Countries (2014-2019)
  • Figure Central & South America Rosacea Drugs Revenue Market Share by Countries in 2019
  • Figure Brazil Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Brazil Rosacea Drugs Revenue Growth Rate (2014-2019) (K Units)
  • Figure Middle East and Africa Rosacea Drugs Sales Growth Rate 2014-2019 (K Units)
  • Figure Middle East and Africa Rosacea Drugs Revenue Growth Rate 2014-2019 (Million US$)
  • Table Middle East and Africa Rosacea Drugs Sales by Type (2014-2019) (K Units)
  • Table Middle East and Africa Rosacea Drugs Sales Market Share by Type (2014-2019)
  • Figure 2017 Middle East and Africa Rosacea Drugs Market Share by Type
  • Table Middle East and Africa Rosacea Drugs Sales by Application (2014-2019) (K Units)
  • Table Middle East and Africa Rosacea Drugs Sales Market Share by Application (2014-2019)
  • Figure 2017 Middle East and Africa Rosacea Drugs Market Share by Application
  • Table Middle East and Africa Rosacea Drugs Sales by Countries (2014-2019) (K Units)
  • Table Middle East and Africa Rosacea Drugs Sales Market Share by Countries (2014-2019)
  • Figure 2017 Middle East and Africa Rosacea Drugs Sales Market Share by Countries
  • Table Middle East and Africa Rosacea Drugs Revenue by Countries (2014-2019) (Million US$)
  • Table Middle East and Africa Rosacea Drugs Revenue Market Share by Countries (2014-2019)
  • Figure 2017 Middle East and Africa Rosacea Drugs Revenue Market Share by Countries
  • Figure GCC Countries Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure GCC Countries Rosacea Drugs Revenue Growth Rate (2014-2019) (K Units)
  • Figure Egypt Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure Egypt Rosacea Drugs Revenue Growth Rate (2014-2019) (K Units)
  • Figure South Africa Rosacea Drugs Sales Growth Rate (2014-2019) (K Units)
  • Figure South Africa Rosacea Drugs Revenue Growth Rate (2014-2019) (K Units)
  • Table Nestle Skin Health Company Details
  • Table Nestle Skin Health Description and Business Overview
  • Table Nestle Skin Health Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Nestle Skin Health Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table Nestle Skin Health Rosacea Drugs Sales Market Share in Global Market
  • Table Nestle Skin Health Recent Development
  • Table Teva Company Details
  • Table Teva Description and Business Overview
  • Table Teva Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Teva Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table Teva Rosacea Drugs Sales Market Share in Global Market
  • Table Teva Recent Development
  • Table Mylan Company Details
  • Table Mylan Description and Business Overview
  • Table Mylan Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Mylan Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table Mylan Rosacea Drugs Sales Market Share in Global Market
  • Table Mylan Recent Development
  • Table Bayer Company Details
  • Table Bayer Description and Business Overview
  • Table Bayer Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Bayer Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table Bayer Rosacea Drugs Sales Market Share in Global Market
  • Table Bayer Recent Development
  • Table Sun Pharma Company Details
  • Table Sun Pharma Description and Business Overview
  • Table Sun Pharma Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Sun Pharma Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table Sun Pharma Rosacea Drugs Sales Market Share in Global Market
  • Table Sun Pharma Recent Development
  • Table Perrigo Company Details
  • Table Perrigo Description and Business Overview
  • Table Perrigo Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Perrigo Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table Perrigo Rosacea Drugs Sales Market Share in Global Market
  • Table Perrigo Recent Development
  • Table Bausch Health Company Details
  • Table Bausch Health Description and Business Overview
  • Table Bausch Health Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Bausch Health Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table Bausch Health Rosacea Drugs Sales Market Share in Global Market
  • Table Bausch Health Recent Development
  • Table GSK Company Details
  • Table GSK Description and Business Overview
  • Table GSK Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table GSK Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table GSK Rosacea Drugs Sales Market Share in Global Market
  • Table GSK Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Description and Business Overview
  • Table Pfizer Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Pfizer Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table Pfizer Rosacea Drugs Sales Market Share in Global Market
  • Table Pfizer Recent Development
  • Table Allergan Company Details
  • Table Allergan Description and Business Overview
  • Table Allergan Rosacea Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Allergan Rosacea Drugs Sales Growth Rate (2014-2019)
  • Table Allergan Rosacea Drugs Sales Market Share in Global Market
  • Table Allergan Recent Development
  • Table Almirall Company Details
  • Figure Rosacea Drugs Value Chain
  • Table Rosacea Drugs Distributors List
  • Table Rosacea Drugs Customers List
  • Table Global Rosacea Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
  • Figure Global Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Global Rosacea Drugs Revenue Forecast 2019-2025 (Million US$)
  • Table Global Rosacea Drugs Sales Forecast by Type 2019-2025 (K Units)
  • Figure Global Rosacea Drugs Sales Forecast by Type 2019-2025 (K Units)
  • Figure Global Rosacea Drugs Sales Market Share Forecast by Type 2019-2025
  • Table Global Rosacea Drugs Sales Forecast by Application 2019-2025 (K Units)
  • Figure Global Rosacea Drugs Sales Forecast by Application 2019-2025 (K Units)
  • Figure Global Rosacea Drugs Sales Market Share Forecast by Application 2019-2025
  • Table Global Rosacea Drugs Sales Forecast by Regions 2019-2025 (K Units)
  • Figure Global Rosacea Drugs Sales Forecast by Regions 2019-2025 (K Units)
  • Figure Global Rosacea Drugs Sales Market Share Forecast by Regions 2019-2025
  • Table Global Rosacea Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
  • Figure Global Rosacea Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
  • Figure Global Rosacea Drugs Revenue Market Share Forecast by Regions 2019-2025
  • Table North America Rosacea Drugs Sales Forecast by Countries 2019-2025 (K Units)
  • Table North America Rosacea Drugs Sales Market Share Forecast by Countries 2019-2025
  • Table North America Rosacea Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table North America Rosacea Drugs Revenue Market Share Forecast by Countries 2019-2025
  • Figure United States Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Canada Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure MexicoRosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Table Europe Rosacea Drugs Sales Forecast by Countries 2019-2025 (K Units)
  • Table Europe Rosacea Drugs Sales Market Share Forecast by Countries 2019-2025
  • Table Europe Rosacea Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table Europe Rosacea Drugs Revenue Market Share Forecast by Countries 2019-2025
  • Figure Germany Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure France Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure UK Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Italy Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Russia Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Table Asia Pacific Rosacea Drugs Sales Forecast by Countries 2019-2025 (K Units)
  • Table Asia Pacific Rosacea Drugs Sales Market Share Forecast by Countries 2019-2025
  • Table Asia Pacific Rosacea Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table Asia Pacific Rosacea Drugs Revenue Market Share Forecast by Countries 2019-2025
  • Figure China Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Japan Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Korea Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure India Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Australia Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Indonesia Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Thailand Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Malaysia Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Philippines Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Figure Vietnam Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Table Central & South America Rosacea Drugs Sales Forecast by Countries 2019-2025 (K Units)
  • Table Central & South America Rosacea Drugs Sales Market Share Forecast by Countries 2019-2025
  • Table Central & South America Rosacea Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table Central & South America Rosacea Drugs Revenue Market Share Forecast by Countries 2019-2025
  • Figure Brazil Rosacea Drugs Sales Forecast 2019-2025 (K Units)
  • Table Middle East and Africa Rosacea Drugs Sales Forecast by Regions 2019-2025 (K Units)
  • Table Middle East and Africa Rosacea Drugs Sales Market Share Forecast by Regions 2019-2025
  • Table Middle East and Africa Rosacea Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
  • Table Middle East and Africa Rosacea Drugs Revenue Market Share Forecast by Regions 2019-2025
  • Figure GCC Countries Rosacea Drugs Sales Growth Rate (2019-2025) (K Units)
  • Figure Egypt Rosacea Drugs Sales Growth Rate (2019-2025) (K Units)
  • Figure South Africa Rosacea Drugs Sales Growth Rate (2019-2025) (K Units)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

Rosacea is a common skin condition characterized by redness and visible blood vessels on the face. The nose and cheeks are the most affected regions. The signs and symptoms of Rosacea are small, red, pus-filled bumps which may flare up periodically. About half the patients experience eye dryness, irritation and swollen, reddened eyelids. Other symptoms include enlarged nose, thickening the skin on the nose, (rhinophyma). Rosacea predominantly affects middle-aged women having fair skin.

In 2018, the global Rosacea Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Rosacea Drugs.

This study researches the market size of Rosacea Drugs, presents the global Rosacea Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.

This report focuses on the key data information of Rosacea Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Rosacea Drugs for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.

  • Nestle Skin Health
  • Teva
  • Mylan
  • Bayer
  • Sun Pharma
  • Perrigo
  • Bausch Health
  • GSK
  • Pfizer
  • Allergan
  • Almirall

Market Segment by Product Type

  • Topical
  • Orals

Market Segment by Application

  • Drugs Stores
  • Hospital
  • Other

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Rosacea Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Rosacea Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Rosacea Drugs are as follows:

  • History Year: 2014-2019
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
    • 1.3.1. Global Rosacea Drugs Market Size Growth Rate by Type
    • 1.3.2. Topical
    • 1.3.3. Orals
  • 1.4. Market Segment by Application
    • 1.4.1. Global Rosacea Drugs Market Share by Application (2018-2025)
    • 1.4.2. Drugs Stores
    • 1.4.3. Hospital
    • 1.4.4. Other
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global Rosacea Drugs Market Size
    • 2.1.1. Global Rosacea Drugs Revenue 2014-2025
    • 2.1.2. Global Rosacea Drugs Sales 2014-2025
  • 2.2. Rosacea Drugs Growth Rate by Regions
    • 2.2.1. Global Rosacea Drugs Sales by Regions 2014-2019
    • 2.2.2. Global Rosacea Drugs Revenue by Regions 2014-2019
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. Rosacea Drugs Sales by Manufacturers
    • 3.1.1. Rosacea Drugs Sales by Manufacturers 2014-2019
    • 3.1.2. Rosacea Drugs Sales Market Share by Manufacturers 2014-2019
  • 3.2. Revenue by Manufacturers
    • 3.2.1. Rosacea Drugs Revenue by Manufacturers (2014-2019)
    • 3.2.2. Rosacea Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.2.3. Global Rosacea Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.3. Rosacea Drugs Price by Manufacturers
  • 3.4. Key Manufacturers Rosacea Drugs Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into Rosacea Drugs Market
  • 3.6. Key Manufacturers Rosacea Drugs Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.1. Sales and Revenue for Each Type
    • 4.1.1. Topical Sales and Revenue (2014-2019)
    • 4.1.2. Orals Sales and Revenue (2014-2019)
  • 4.2. Global Rosacea Drugs Sales Market Share by Type
  • 4.3. Global Rosacea Drugs Revenue Market Share by Type
  • 4.4. Rosacea Drugs Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global Rosacea Drugs Sales by Application

6. North America

  • 6.1. North America Rosacea Drugs Breakdown Data by Company
  • 6.2. North America Rosacea Drugs Breakdown Data by Type
  • 6.3. North America Rosacea Drugs Breakdown Data by Application
  • 6.4. North America Rosacea Drugs Breakdown Data by Countries
    • 6.4.1. North America Rosacea Drugs Sales by Countries
    • 6.4.2. North America Rosacea Drugs Revenue by Countries
    • 6.4.3. United States
    • 6.4.4. Canada
    • 6.4.5. Mexico

7. Europe

  • 7.1. Europe Rosacea Drugs Breakdown Data by Company
  • 7.2. Europe Rosacea Drugs Breakdown Data by Type
  • 7.3. Europe Rosacea Drugs Breakdown Data by Application
  • 7.4. Europe Rosacea Drugs Breakdown Data by Countries
    • 7.4.1. Europe Rosacea Drugs Sales by Countries
    • 7.4.2. Europe Rosacea Drugs Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. UK
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Rosacea Drugs Breakdown Data by Company
  • 8.2. Asia Pacific Rosacea Drugs Breakdown Data by Type
  • 8.3. Asia Pacific Rosacea Drugs Breakdown Data by Application
  • 8.4. Asia Pacific Rosacea Drugs Breakdown Data by Countries
    • 8.4.1. Asia Pacific Rosacea Drugs Sales by Countries
    • 8.4.2. Asia Pacific Rosacea Drugs Revenue by Countries
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Indonesia
    • 8.4.9. Malaysia
    • 8.4.10. Philippines
    • 8.4.11. Thailand
    • 8.4.12. Vietnam

9. Central & South America

  • 9.1. Central & South America Rosacea Drugs Breakdown Data by Company
  • 9.2. Central & South America Rosacea Drugs Breakdown Data by Type
  • 9.3. Central & South America Rosacea Drugs Breakdown Data by Application
  • 9.4. Central & South America Rosacea Drugs Breakdown Data by Countries
    • 9.4.1. Central & South America Rosacea Drugs Sales by Countries
    • 9.4.2. Central & South America Rosacea Drugs Revenue by Countries
    • 9.4.3. Brazil

10. Middle East and Africa

  • 10.1. Middle East and Africa Rosacea Drugs Breakdown Data by Type
  • 10.2. Middle East and Africa Rosacea Drugs Breakdown Data by Application
  • 10.3. Middle East and Africa Rosacea Drugs Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Rosacea Drugs Sales by Countries
    • 10.3.2. Middle East and Africa Rosacea Drugs Revenue by Countries
    • 10.3.3. GCC Countries
    • 10.3.4. Egypt
    • 10.3.5. South Africa

11. Company Profiles

  • 11.1. Nestle Skin Health
    • 11.1.1. Nestle Skin Health Company Details
    • 11.1.2. Company Description and Business Overview
    • 11.1.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.1.4. Rosacea Drugs Product Introduction
    • 11.1.5. Nestle Skin Health Recent Development
  • 11.2. Teva
    • 11.2.1. Teva Company Details
    • 11.2.2. Company Description and Business Overview
    • 11.2.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.2.4. Rosacea Drugs Product Introduction
    • 11.2.5. Teva Recent Development
  • 11.3. Mylan
    • 11.3.1. Mylan Company Details
    • 11.3.2. Company Description and Business Overview
    • 11.3.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.3.4. Rosacea Drugs Product Introduction
    • 11.3.5. Mylan Recent Development
  • 11.4. Bayer
    • 11.4.1. Bayer Company Details
    • 11.4.2. Company Description and Business Overview
    • 11.4.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.4.4. Rosacea Drugs Product Introduction
    • 11.4.5. Bayer Recent Development
  • 11.5. Sun Pharma
    • 11.5.1. Sun Pharma Company Details
    • 11.5.2. Company Description and Business Overview
    • 11.5.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.5.4. Rosacea Drugs Product Introduction
    • 11.5.5. Sun Pharma Recent Development
  • 11.6. Perrigo
    • 11.6.1. Perrigo Company Details
    • 11.6.2. Company Description and Business Overview
    • 11.6.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.6.4. Rosacea Drugs Product Introduction
    • 11.6.5. Perrigo Recent Development
  • 11.7. Bausch Health
    • 11.7.1. Bausch Health Company Details
    • 11.7.2. Company Description and Business Overview
    • 11.7.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.7.4. Rosacea Drugs Product Introduction
    • 11.7.5. Bausch Health Recent Development
  • 11.8. GSK
    • 11.8.1. GSK Company Details
    • 11.8.2. Company Description and Business Overview
    • 11.8.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.8.4. Rosacea Drugs Product Introduction
    • 11.8.5. GSK Recent Development
  • 11.9. Pfizer
    • 11.9.1. Pfizer Company Details
    • 11.9.2. Company Description and Business Overview
    • 11.9.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.9.4. Rosacea Drugs Product Introduction
    • 11.9.5. Pfizer Recent Development
  • 11.10. Allergan
    • 11.10.1. Allergan Company Details
    • 11.10.2. Company Description and Business Overview
    • 11.10.3. Sales, Revenue and Market Share of Rosacea Drugs
    • 11.10.4. Rosacea Drugs Product Introduction
    • 11.10.5. Allergan Recent Development
  • 11.11. Almirall

12. Value Chain and Sales Channels Analysis

  • 12.1. Value Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Rosacea Drugs Sales Channels
    • 12.2.2. Rosacea Drugs Distributors
  • 12.3. Rosacea Drugs Customers

13. Market Forecast

  • 13.1. Global Rosacea Drugs Sales and Revenue Forecast 2019-2025
  • 13.2. Global Rosacea Drugs Sales Forecast by Type
  • 13.3. Global Rosacea Drugs Sales Forecast by Application
  • 13.4. Rosacea Drugs Forecast by Regions
    • 13.4.1. Global Rosacea Drugs Sales Forecast by Regions 2019-2025
    • 13.4.2. Global Rosacea Drugs Revenue Forecast by Regions 2019-2025
  • 13.5. North America Market Forecast
    • 13.5.1. North America Rosacea Drugs Forecast by Countries 2019-2025
    • 13.5.2. United States
    • 13.5.3. Canada
    • 13.5.4. Mexico
  • 13.6. Europe Market Forecast
    • 13.6.1. Europe Rosacea Drugs Forecast by Countries 2019-2025
    • 13.6.2. Germany
    • 13.6.3. France
    • 13.6.4. UK
    • 13.6.5. Italy
    • 13.6.6. Russia
  • 13.7. Asia Pacific Market Forecast
    • 13.7.1. Asia Pacific Rosacea Drugs Sales Forecast by Countries 2019-2025
    • 13.7.2. China
    • 13.7.3. Japan
    • 13.7.4. Korea
    • 13.7.5. India
    • 13.7.6. Australia
    • 13.7.7. Indonesia
    • 13.7.8. Thailand
    • 13.7.9. Malaysia
    • 13.7.10. Philippines
    • 13.7.11. Vietnam
  • 13.8. Central & South America Market Forecast
    • 13.8.1. Central & South America Rosacea Drugs Sales Forecast by Countries 2019-2025
    • 13.8.2. Brazil
  • 13.9. Middle East and Africa Market Forecast
    • 13.9.1. Middle East and Africa Rosacea Drugs Sales Forecast by Countries 2019-2025
    • 13.9.2. GCC Countries
    • 13.9.3. Egypt
    • 13.9.4. South Africa

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 13.1.2.2. Primary Sources
  • 15.2. Author Details
  • 15.3. Disclaimer
Back to Top